抗体

Antibodies

OriGene 拥有成熟的抗体研发平台和抗体鉴定平台。目前可提供丰富的抗体产品,产品的数量多,类型丰富,基因覆盖度高,可满足科学研究者不同的实验需求。

OriGene拥有超过90,000种一抗以及常用的二抗和标签抗体,抗体种类多样,包含多种种属。通过先进的技术制备免疫原,获得抗体后经过多重验证。我们高品质的抗体品牌包括:TrueMAB®, UltraMAB®, 和 TrueRAB®

查看不同类型抗体:

优势一抗品牌

抗体特异性验证方案

产品特异性是抗体特性非常重要的一个方面。OriGene 在抗体开发过程中,采用多种方式来进行产品特异性验证。

验证方式

  • 根据预测分子量大小,通过Western blot进行分析
  • 独立抗体特异性验证策略
  • 10k /17K高密度蛋白芯片验证
  • 使用CRISPR技术敲除细胞系(KO)验证

验证数据示例

Specificity Validation for OriGene antibody Cat. No. UM500036
anti-her2 validation with over expression and endogenous lysates

Figure 1. Specificity validation of anti-Her2 antibody (Cat. No. UM500036) using human Her2 overexpression cell lysates and endogenous cell line lysates. UM500036 can recognize the specific Her2 protein at predicted size (~140KDa) in overexpression cell ysate (lane 1 ) and endogenous lysates prepared from Hela, A549 and MCF7 cell lines. The specificity is further proved by using an independent antibody (anti-DDK antibody in the middle) against the same recombinant overexpressed Her2 protein.

anti-her2 validation with 10k protein chip

Figure 2. Specificity validation of anti-Her2 antibody (Cat. No. UM500036) using 10k protein chip technology. UM500036 shows no cross-reactivity with other protein on the tested protein microarray containing >10,000 overexpression lysates for different human proteins.

anti-her2 validation with-ko cell ysate

Figure 3. Specificity validation of anti-Her2 antibody (Cat. No. UM500036) using Her2 knockout cell lysate. UM500036 recognizes the specific Her2 protein at correct size in wild type Hela cell lysate (WT lane), and shows cross-reactivity with any other protein in the double knockout cell lysates (KO lane).
WT: parental wild type Hela cell lysate
KO: Her2 double knockout Hela cell lysate

近期文献应用

1. Saikosaponin A protects against uremic toxin indole‑3 acetic acid‑induced damage to the myocardium

Published in Molecular Medicine Reports, 2023 Sep, using TA130015
PubMed: 37417356

2. Targeting ANXA7/LAMP5-mTOR axis attenuates spinal cord injury by inhibiting neuronal apoptosis via enhancing autophagy in mice

Published in Cell Death Discovery, 2023 Aug, using R1107
PubMed: 37620352

3. A pH‑responsive hyaluronic acid nano‑vehicle co‑encapsulating doxorubicin and all‑trans retinoic acid for the inhibition of hepatic stellate cell‑induced tumor growth and metastasis

Published in Molecular Medicine Reports, 2023 Aug, using TA130015
PubMed: 37326031

See all »